Simcere Pharmaceutical Group Limited (FRA:S2P)
Germany
· Delayed Price · Currency is EUR 0.9550
+0.0050 (0.53%)
At close: May 13, 2025, 10:00 PM CET
FRA:S2P Revenue
In the year 2024, Simcere Pharmaceutical Group had annual revenue of 6.64B CNY with 0.41% growth. Simcere Pharmaceutical Group had revenue of 3.52B in the half year ending December 31, 2024, a decrease of -2.83%.
Revenue
6.64B CNY
Revenue Growth
+0.41%
P/S Ratio
2.71
Revenue / Employee
1.01M CNY
Employees
6,584
Market Cap
2.38B EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.64B | 27.41M | 0.41% |
| Dec 31, 2023 | 6.61B | 283.72M | 4.49% |
| Dec 31, 2022 | 6.32B | 1.32B | 26.49% |
| Dec 31, 2021 | 5.00B | 491.00M | 10.89% |
| Dec 31, 2020 | 4.51B | -527.94M | -10.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 35.15B |
| Siemens Aktiengesellschaft | 76.54B |
| Deutsche Telekom AG | 118.43B |
| Allianz SE | 107.35B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.15B |
| Rheinmetall AG | 10.48B |
| Siemens Energy AG | 37.44B |
| Merck KGaA | 21.16B |